Search Results - "Cooper, Maryann R"

The Role of Denosumab for Prevention of Skeletal-Related Complications in Multiple Myeloma by Hageman, Kelly, Patel, Kiki Chandni, Mace, Kimberly, Cooper, Maryann R

“…OBJECTIVE To evaluate the use of denosumab for the prevention of skeletal-related events (SREs) in patients with osteolytic lesions associated with multiple…”
Get full text

Reversible ageusia associated with romidepsin therapy by COOPER, MARYANN R., BREWER, SARA, BROKETA, GORAN

“…PURPOSEThe case of a patient who reported the complete loss of his sense of taste after about 3.5 months of romidepsin therapy is presented. SUMMARYA man with…”
Get full text

Assessment of a Mindfulness Meditation Elective in an Accelerated Doctor of Pharmacy Program by Durand, Cheryl, Cooper, Maryann R., Goldsmith, Carroll-Ann

“…Objective. The objective of this study was to determine the effect of a live 14-week mindfulness elective course on the well-being of Doctor of Pharmacy…”
Get full text

Exploring the effects of a smartphone-based meditation app on stress, mindfulness, well-being, and resilience in pharmacy students by Truhlar, Laura M, Durand, Cheryl, Cooper, Maryann R, Goldsmith, Carroll-Ann W

“…PURPOSEThe purpose of this study was to investigate the effects of the smartphone-based meditation app Ten Percent Happier on stress, mindfulness, well-being,…”
Get full text

Assessment of a Mindfulness Meditation Elective in an Accelerated Doctor of Pharmacy Program by Durand, Cheryl, Cooper, Maryann R, Goldsmith, Carroll-Ann

“…Objective. The objective of this study was to determine the effect of a live 14-week mindfulness elective course on the well-being of Doctor of Pharmacy…”
Get full text

Ceritinib: A New Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer by Cooper, Maryann R., Chim, Helen, Chan, Hoyi, Durand, Cheryl

“…Objective: To review ceritinib for the treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non–small-cell lung cancer (NSCLC). Data Sources:…”
Get full text

Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer by Cooper, Maryann R, Alrajhi, Abdullah M, Durand, Cheryl R

“…Small cell lung cancer (SCLC) accounts for approximately 13% of all lung cancer diagnoses each year. SCLC is characterized by a rapid doubling time, early…”
Get full text

Vandetanib for the Treatment of Medullary Thyroid Carcinoma by Cooper, Maryann R., Yi, Soo Yun, Alghamdi, Wael, Shaheen, Daniel J., Steinberg, Michael

“…Objective: To review the place in therapy of vandetanib for medullary thyroid carcinoma (MTC). Data Sources: Literature searches were performed in Ovid…”
Get full text

Dosing of Enoxaparin for Venous Thromboembolism Prophylaxis in Obese Patients by Willett, Kristine C., Alsharhan, Mohammad, Durand, Cheryl, Cooper, Maryann R.

“…Objective: To evaluate the appropriate dosing of enoxaparin as a venous thromboembolism (VTE) prophylaxis in hospitalized obese patients. Data Sources:…”
Get full text

Efficacy and Safety of Modafinil in the Treatment of Cancer-Related Fatigue by Cooper, Maryann R, Bird, Heather M, Steinberg, Michael

“…Objective: To review the efficacy and safety of modafinil in the treatment of cancer-related fatigue (CRF). Data Souces: Literature was accessed via MEDLINE…”
Get full text

Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer by Cooper, Maryann R, Binkowski, Chelsea, Hartung, Jessica, Towle, Jennifer

“…The interaction between vascular endothelial growth factor and its receptor is an important therapeutic target due to the importance of this pathway in…”
Get full text

Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2–positive metastatic breast cancer by PATEL, KIKI CHANDNI, HAGEMAN, KELLY, COOPER, MARYANN R

“…PURPOSEAn update on completed and ongoing clinical trials of ado-trastuzumab emtansine for the treatment of metastatic breast cancer (MBC) is presented…”
Get full text

Single-Agent, Broad-Spectrum Fluoroquinolones for the Outpatient Treatment of Low-Risk Febrile Neutropenia by Cooper, Maryann R, Durand, Cheryl R, Beaulac, Matthew T, Steinberg, Michael

“…Objective: To evaluate the use of oral, single-agent, broad-spectrum fluoroquinolones in the treatment of low-risk febrile neutropenia (FN). Data Sources:…”
Get full text

Description of a Medication Disposal Event in a Managed Care Setting by PERVANAS, Helen C, COOPER, Maryann R, LENZA, Robert

Get full text

Health Perception Changes of State Employees following a Health Screening Event by Pervanas, Helen C, Silva, Matthew A, Willett, Kristine C, Cooper, Maryann R, Durand, Cheryl, Belliveau, Paul, Abel, Cheryl

“…Background: Health screenings can identify patients at risk for chronic medical conditions. Additionally, screenings may influence behavior changes as depicted…”
Get full text

Nivolumab for the Treatment of Classical Hodgkin Lymphoma by Cooper, Maryann R., Almalki, Bassem, Willett, Kristine C.

“…Objective: To review nivolumab for the treatment of classical Hodgkin lymphoma (cHL). Data Sources: Literature searches were conducted in Medline (1946 to May…”
Get full text